SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-316898
Filing Date
2019-12-18
Accepted
2019-12-18 09:07:03
Documents
10
Period of Report
2020-01-29
Effectiveness Date
2019-12-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d824987ddef14a.htm DEF 14A 610132
2 GRAPHIC g824987g35f49.jpg GRAPHIC 3362
3 GRAPHIC g824987g90c41.jpg GRAPHIC 30624
4 GRAPHIC g824987gr01.jpg GRAPHIC 9232
5 GRAPHIC g824987gra0001.jpg GRAPHIC 8388
6 GRAPHIC g824987gra001.jpg GRAPHIC 9927
7 GRAPHIC g824987gra037.jpg GRAPHIC 8355
8 GRAPHIC g824987gra038.jpg GRAPHIC 8384
9 GRAPHIC g824987gra039.jpg GRAPHIC 8378
10 GRAPHIC g824987page35.jpg GRAPHIC 2175
  Complete submission text file 0001193125-19-316898.txt   675057
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-14902 | Film No.: 191291432
SIC: 2835 In Vitro & In Vivo Diagnostic Substances